Therefore, rescue experiments clearly indicated that PHF5A inhibition could reverse the effect of the DOCK5 variant in HNSCC, which suggested that PHF5A regulated the expression of the DOCK5 variant to promote the progression of HNSCC. This evidence concerns the gene PHF5A and head and neck squamous cell carcinoma.